Invention Grant
US07902163B2 Antisense modulation of superoxide dismutase 1, soluble expression
有权
反义调制超氧化物歧化酶1，可溶性表达
- Patent Title: Antisense modulation of superoxide dismutase 1, soluble expression
- Patent Title (中): 反义调制超氧化物歧化酶1，可溶性表达
-
Application No.: US11449446Application Date: 2006-06-07
-
Publication No.: US07902163B2Publication Date: 2011-03-08
- Inventor: C. Frank Bennett , Kenneth W. Dobie , Susan M. Freier
- Applicant: C. Frank Bennett , Kenneth W. Dobie , Susan M. Freier
- Applicant Address: US CA Carlsbad
- Assignee: Isis Pharmaceuticals, Inc.
- Current Assignee: Isis Pharmaceuticals, Inc.
- Current Assignee Address: US CA Carlsbad
- Agency: Jones Day
- Main IPC: C07H21/02
- IPC: C07H21/02 ; C07H21/04 ; A01N43/04 ; A61K31/70
Abstract:
Antisense compounds, compositions and methods are provided for modulating the expression of superoxide dismutase 1, soluble. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding superoxide dismutase 1, soluble. Methods of using these compounds for modulation of superoxide dismutase 1, soluble expression and for treatment of diseases associated with expression of superoxide dismutase 1, soluble are provided.
Public/Granted literature
- US20070054869A1 Antisense modulation of superoxide dismutase 1, soluble expression Public/Granted day:2007-03-08
Information query
